Preservation of β-Cells as a Therapeutic Strategy for Diabetes
Hormone and Metabolic Research · 2024-04 · 56 (04) · 261-271
DOI: 10.1055/a-2239-2668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, online erschienen am 22.02.2024. Verfasst von Jalal Taneera und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of Sharjah, Sharjah, United Arab Emirates. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Insulin Resistance, Insulin-Secreting Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The preservation of pancreatic islet β-cells is crucial in diabetes mellitus, encompassing both type 1 and type 2 diabetes. β-cell dysfunction, reduced mass, and apoptosis are central to insufficient insulin secretion in both types. Research is focused on understanding β-cell characteristics and the factors regulating their function to develop novel therapeutic approaches. In type 1 diabetes (T1D), β-cell destruction by the immune system calls for exploring immunosuppressive therapies, non-steroidal anti-inflammatory drugs, and leukotriene antagonists. Islet transplantation, stem cell therapy, and xenogeneic transplantation offer promising strategies for type 1 diabetes treatment. For type 2 diabetes (T2D), lifestyle changes like weight loss and exercise enhance insulin sensitivity and maintain β-cell function. Additionally, various pharmacological approaches, such as cytokine inhibitors and protein kinase inhibitors, are being investigated to protect β-cells from inflammation and glucotoxicity. Bariatric surgery emerges as an effective treatment for obesity and T2D by promoting β-cell survival and function. It improves insulin sensitivity, modulates gut hormones, and expands β-cell mass, leading to diabetes remission and better glycemic control. In conclusion, preserving β-cells offers a promising approach to managing both types of diabetes. By combining lifestyle modifications, targeted pharmacological interventions, and advanced therapies like stem cell transplantation and bariatric surgery, we have a significant chance to preserve β-cell function and enhance glucose regulation in diabetic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
- Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
ORCID-Profile: Jalal Taneera
Zitieren
APA
Taneera, J., & Saber-Ayad, M. M. (2024). Preservation of β-Cells as a Therapeutic Strategy for Diabetes. Hormone and Metabolic Research, 56(04), 261-271. https://doi.org/10.1055/a-2239-2668
Vancouver
Taneera J, Saber-Ayad MM. Preservation of β-Cells as a Therapeutic Strategy for Diabetes. Hormone and Metabolic Research. 2024;56(04):261-271. doi:10.1055/a-2239-2668
BibTeX
@article{Taneera2024,
author = {Taneera, Jalal and Saber-Ayad, Maha M},
title = {Preservation of β-Cells as a Therapeutic Strategy for Diabetes},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {04},
pages = {261--271},
doi = {10.1055/a-2239-2668}
}
EUVIMED